Press Releases by Category Health & Medicine
Cell Culture Media Market Projected to Grow at 10.4% CAGR Through 2032, Notes Pe …
Cell culture media is a critical component in biotechnology, pharmaceuticals, and life sciences research. These media provide the nutrients and environment necessary to support the growth of cells in vitro for a wide range of applications, including drug development, cancer research, regenerative medicine, and tissue engineering. As the demand for precision medicine and biologics continues to grow, so does the importance of high-quality cell culture media to enable these advancements.…
Neuropathic Pain Market to Hit US$ 14.34 Bn by 2033, Driven by Rising Chronic Pa …
✅ Global Neuropathic Pain Market: Analysis, Growth Drivers, and Future Outlook
The global neuropathic pain market is undergoing substantial transformation, driven by the increasing prevalence of chronic diseases, an aging global population, and advancements in pain management therapies. According to recent market insights, the global revenue from the neuropathic pain market stood at approximately US$ 7.62 Billion in 2022, and it is forecasted to reach US$ 14.34 Billion by 2033, growing…
Private Healthcare Market to Hit US$ 3,415.1 Bn by 2032, Driven by Aging Populat …
✅ Private Healthcare Market: Rising Demand, Innovation, and Global Expansion
The private healthcare market has seen a significant transformation over the past decade, fueled by rising demand for personalized services, faster access to treatments, and growing dissatisfaction with public healthcare systems in various countries. As global healthcare needs become increasingly complex and patient-centric, the private sector continues to gain traction across both developed and emerging economies. According to recent data, the…
Cosmetic Threads Market to Reach US$ 255.7 Mn by 2033 Driven by Minimally Invasi …
✅ Cosmetic Threads Market: Global Growth, Trends, and Forecast to 2033
The global cosmetic threads market has shown impressive growth and is poised for even more significant expansion in the coming years. In 2022, the global revenue stood at US$ 129.9 million, with projections estimating the market to reach US$ 255.7 million by 2033, expanding at a CAGR of 6.3%. This growth is largely attributed to the rising demand for minimally…
Telemedicine Market to Reach US$ 372.5 Bn by 2032, Driven by Tech Adoption and C …
✅ Global Telemedicine Market: Unprecedented Growth Forecast from 2025 to 2032
According to the Persistence Market Research report, the global telemedicine market size is poised for explosive expansion, projected to grow from US$ 108.4 Bn in 2025 to US$ 372.5 Bn by 2032, registering an impressive CAGR of 19.3% over the forecast period. The growth is primarily driven by evolving healthcare delivery models, the integration of digital technology, and an urgent…
Aging Population Dynamics Is A Catalyst For Expanding Horizons In The Durable Me …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Durable Medical Equipment Market Size Growth Forecast: What to Expect by 2025?
In recent years, the durable medical equipment market has experienced significant growth. It is projected to increase from a size of $216.92 billion in 2024 to $231.73 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The factors contributing…
Medical Wellness Market to Reach US$ 5,524.3 Bn by 2033, Driven by Lifestyle & A …
✅Market Overview and Growth Outlook
The global medical wellness market stood at an impressive valuation of US$ 1,309.1 Bn in 2022. Fueled by increasing health awareness, preventive care focus, and a shift toward holistic wellness approaches, the market is poised to experience exponential growth. According to industry estimates, the market is set to reach US$ 5,524.3 Bn by the end of 2033, expanding at a CAGR of 14.0% over the forecast…
Cosmetic CDMO Market to Reach US$36.1 Bn by 2031, Driven by Demand for Custom Fo …
✅ Cosmetic CDMO Market Outlook: Growth Trajectory and Key Trends to 2031
The global Cosmetic Contract Development and Manufacturing Organization (CDMO) market is gaining unprecedented traction as cosmetic brands increasingly outsource their product development and manufacturing to specialist firms. According to industry estimates, the worldwide revenue from the cosmetic CDMO market is anticipated to reach US$23.5 Bn in 2024 and is forecasted to surge to US$36.1 Bn by the end of…
Acupuncture Treatment Market to Hit US$ 95.0 Bn by 2032 Driven by Chronic Pain D …
✅Acupuncture Treatment Market Overview
The global acupuncture treatment market has seen remarkable growth in recent years, with worldwide revenue reaching US$ 37.4 billion by the end of 2024. This surge in demand reflects growing awareness of holistic healing techniques and the increasing shift towards non-pharmaceutical therapies for chronic conditions and wellness management. As alternative medicine becomes more mainstream, acupuncture continues to carve a strong niche globally.
According to market analysis, the acupuncture…
Expectorant Drugs Market valued at USD 16.4 Bn in 2023; projected to grow at a C …
The global expectant drugs market is witnessing robust growth, driven by an uptick in respiratory ailments, a growing aging population, and the launch of innovative over-the-counter (OTC) medications. According to a recent industry report, the global market was valued at US$ 16.4 billion in 2023 and is expected to grow at a CAGR of 4.7%, reaching US$ 27.1 billion by 2034.
This growth is further fueled by strategic actions from leading…
Exosome Isolation Market to Reach USD 1.2 Billion by 2034, Driven by Advancement …
The global Exosome Isolation Market, valued at US$ 370.7 million in 2023, is poised for significant expansion, projected to reach US$ 1.2 billion by the end of 2034. With a robust CAGR of 11.6% from 2024 to 2034, the market is witnessing strong momentum, propelled by rising applications in disease diagnostics, drug delivery systems, and precision medicine. Leading players such as Thermo Fisher Scientific Inc., QIAGEN N.V., Miltenyi Biotec, and…
Epidermal Growth Factors (EGFs) Market Outlook 2034: A Promising Growth Trajecto …
The global Epidermal Growth Factors (EGFs) market is poised for robust expansion, reaching a projected value of US$ 3.7 billion by 2034, up from US$ 1.1 billion in 2023, growing at a compound annual growth rate (CAGR) of 11.3% between 2024 and 2034. The market is experiencing dynamic transformations due to rapid technological innovations, a rise in chronic disease incidence, and increased demand for regenerative medicine and oncology treatments.
Access key…
Esophageal Cancer Market Size to Grow from USD 2.2 Bn in 2023 to USD 4.6 Bn by 2 …
Esophageal cancer remains one of the most challenging malignancies globally, with high mortality rates and limited early detection capabilities. Recent advances in targeted therapies, immunotherapies, and diagnostic techniques have significantly improved patient outcomes. As awareness and early screening programs improve globally, coupled with new drug developments and regulatory approvals, the esophageal cancer market is undergoing a transformational shift. The push for personalized medicine and increasing R&D investments have contributed to…
Driving Cryostat Market Growth in 2025: The Role of Rising Prevalence Of Neuromu …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Cryostat Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size for cryostats has seen significant expansion. The market, which was valued at $2.56 billion in 2024, is slated to grow to $2.7 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.5%. The noted growth over…
Hot and Cold Packs Market to Reach US$ 1.82 Bn by 2032, Driven by Injury Recover …
✅Global Hot and Cold Packs Market Overview
The global hot and cold packs market recorded a valuation of US$ 974.7 million in 2021 and is projected to reach US$ 1.82 billion by 2032, expanding at a CAGR of 5.9% over the forecast period. Hot and cold packs have become indispensable tools in pain relief therapy, physical rehabilitation, sports medicine, and everyday injury treatment. With increasing health awareness and growing demand for…
Life Science Market Driven by Technological Advancements and Rising Healthcare D …
✅ Life Science Market: Innovation, Growth, and Strategic Transformation
The life science market is at the forefront of scientific innovation, transforming healthcare, agriculture, biotechnology, and pharmaceuticals. Rapid advancements in genomics, bioinformatics, and personalized medicine are revolutionizing disease treatment and prevention. According to Persistence Market Research, the global life science market is projected to grow significantly, reaching a valuation of US$ 378.2 billion in 2025, and is anticipated to hit US$ 678.4…
Strategic Forecast for the Circulating Tumor Cells Industry: Market Outlook 2025 …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Circulating Tumor Cells Market Size Growth Forecast: What to Expect by 2025?
The market size for circulating tumor cells has seen significant expansion in the past few years. It is predicted to rise from $11.9 billion in 2024 to $13.37 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.4%. Factors such…
Non-Emergency Medical Transportation Market to Hit US$ 22.3 Bn by 2032, Driven b …
✅ Non-Emergency Medical Transportation Market: A Vital Link in Healthcare Access
The global non-emergency medical transportation (NEMT) market is playing an increasingly critical role in modern healthcare systems. As of 2022, the market is valued at approximately US$ 9,438.17 million, driven by rising demand for patient-friendly transport solutions, especially among the elderly and disabled populations. According to current projections, the market is expected to grow at a CAGR of 9%, reaching…
Driving Catalepsy Treatment Market Growth in 2025: The Role of Rising Prevalence …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Catalepsy Treatment Market Size Growth Forecast: What to Expect by 2025?
The market for catalepsy treatment has seen robust growth in the past few years. It is predicted to escalate from $87.07 billion in 2024 to $92.7 billion in 2025 reflecting a compound annual growth rate (CAGR) of 6.5%. The growth witnessed in the…
United States Cardiac Holter Monitor Market is Booming and Expected to Hit USD 2 …
Market Overview 2025-2033
The United States cardiac holter monitor market size reached USD 164.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 229.1 Million by 2033, exhibiting a growth rate (CAGR) of 3.70% during 2025-2033. The market is experiencing rapid growth, driven by rising cardiovascular disease prevalence, an aging population, and technological advancements. Key trends include increasing adoption of wireless and wearable Holter monitors, with major…
CMO/CDMO Biotechnology Market to Hit US$ 34.1 Bn by 2033, Driven by Biologics De …
✅ Global CMO/CDMO Biotechnology Market: Projected to Reach US$ 34.1 Bn by 2033
The global CMO/CDMO (Contract Manufacturing Organization/Contract Development and Manufacturing Organization) biotechnology market is undergoing significant expansion, reflecting the increasing reliance of pharmaceutical and biotechnology companies on outsourcing strategies. In 2022, the market generated revenue worth US$ 10.2 Bn and is projected to grow at a robust CAGR of 11.6% to reach approximately US$ 34.1 Bn by the end…
Rising Prevalence Of Cardiovascular Diseases Propels Growth In The Calcium Chann …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Calcium Channel Blocker Market Size Growth Forecast: What to Expect by 2025?
In recent times, the size of the calcium channel blocker market has seen robust growth. A rise from $15.56 billion in 2024 to $16.62 billion in 2025 at a compound annual growth rate (CAGR) of 6.8% is predicted. This growth experienced in…
Future of the Bronchitis Treatment Market: Trends, Innovations, and Key Forecast …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Bronchitis Treatment Market Size Growth Forecast: What to Expect by 2025?
The market for bronchitis treatment has seen robust growth in the past years. An expansion from $5.61 billion in 2024 to $5.94 billion in 2025 is projected, corresponding to a compound annual growth rate (CAGR) of 5.8%. The past growth can be linked…
Navigating the Future: Biotech Ingredient Market Trends and Forecast Insights, 2 …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Biotech Ingredient Market Size Growth Forecast: What to Expect by 2025?
In recent years, a robust growth has been observed in the biotech ingredient market. Anticipated to increase from $59.9 billion in 2024 to $63.86 billion in 2025, the market's compound annual growth rate (CAGR) is predicted at 6.6%. This growth trend in the…
Strategic Forecast for the Biologic & Biosimilar RA Drugs Industry: Market Outlo …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Biologic & Biosimilar RA Drugs Market Size Growth Forecast: What to Expect by 2025?
In recent times, the biologic & biosimilar ra drugs market has seen substantial growth. Rising from $13.99 billion in 2024, the market is projected to further increase to $14.71 billion in 2025, with a compound annual growth rate (CAGR) of…
Rising Addiction Linked To Smoking Fuels Growth In Quit-Smoking Drug Market: Cri …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Quit Smoking Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for drugs that help quit smoking has seen fast-paced expansion in the recent past. The market, which stood at $39.26 billion in 2024, is predicted to balloon up to $44.62 billion in 2025, boasting a compound…
Key Trends Influencing the Growth of the Plasma Protein Therapeutics Market in 2 …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Plasma Protein Therapeutics Market Through 2025?
Over the past few years, the plasma protein therapeutics market has observed a robust growth. It is projected to rise from $31.86 billion in 2024 to $34.55 billion in 2025, at a compound annual growth rate (CAGR) of 8.5%. The historic…
Autogenous Vaccines Market Poised for 5.4% CAGR Growth Through 2032, Says Persis …
Market Overview
The global autogenous vaccines market is undergoing rapid transformation, driven by the increasing demand for customized veterinary solutions that address farm-specific pathogens. According to industry analysis, the market is projected to grow at a robust CAGR of 5.4% through 2032. This surge in demand is largely attributed to heightened awareness around antimicrobial resistance (AMR), regulatory shifts discouraging prophylactic antibiotic usage, and the rising incidence of emerging diseases in livestock…
Rising Pet Health Expenditure Fuels Growth In The Pet Diabetes Care Device Marke …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Will the Pet Diabetes Care Devices Industry Market Size Be by 2025?
The market size for pet diabetes care devices has experienced substantial growth in the past few years. The market, which was valued at $2.56 billion in 2024, is forecasted to expand to $2.74 billion in 2025, with a 7.0% compound annual…
Europe Autogenous Vaccines Market to Reach US$ 155.1 Million by 2032, Reveals Pe …
Market Overview
The Europe autogenous vaccines market is witnessing sustained growth, with projections indicating a market value increase from US$ 108.3 million in 2025 to US$ 155.1 million by 2032. This represents a compound annual growth rate (CAGR) of 5.3% over the forecast period. Autogenous vaccines, customized using pathogens from specific herds or flocks, are becoming increasingly crucial as Europe intensifies its focus on preventive veterinary care and antimicrobial resistance (AMR)…
Rediscover Connection: Expert Marriage and Relationship Counselling in Birmingha …
Phinity Therapy offers expert marriage and relationship counselling in Birmingham, helping couples rediscover connection and improve communication. With experienced counsellors, their marriage counselling services address common issues like trust and emotional distance. Relationship counselling Birmingham provides a safe space for couples to explore their concerns and build stronger connections. Phinity Therapy provides professional guidance tailored to your needs.
Relationships are at the heart of our personal lives, and when things aren't…
Orthodontist SEO Launches in Stockton, New Jersey to Elevate Orthodontic Practic …
Image: https://www.globalnewslines.com/uploads/2025/07/1751384003.jpg
Stockton, NJ - July 1st, 2025 - Orthodontist SEO, a newly established digital marketing agency specializing exclusively in orthodontic practice growth, has officially launched to provide expert SEO, web design, and PPC services tailored specifically for orthodontists across the United States.
Image: https://www.globalnewslines.com/uploads/2025/07/7c11ae8e4f43424449348547b1768333.jpg
Based in Stockton, New Jersey, Orthodontist SEO understands the unique challenges orthodontic practices face in attracting and retaining patients in an increasingly competitive market. The company offers customized…
Valley Optometry Eyecare Expands their Ortho-K Services for Myopia Management in …
Image: https://www.globalnewslines.com/uploads/2025/07/1751384731.jpg
Valley Optometry Eyecare has come up with a new non-surgical way of vision correction. The ortho-k treatment is now available to many patients in Reseda. The center provides high-technology myopia control using ortho-k lenses, which helps in reducing the dependency on glasses or daytime contact lenses by both children and adults.
Orthokeratology is an individual treatment plan that alters the cornea's shape at night. Special gas-permeable contact lenses are fitted…
Valley Optometry Eyecare Offers Advanced Orthokeratology Services for Myopia Man …
Image: https://www.globalnewslines.com/uploads/2025/07/1751384653.jpg
Valley Optometry Eyecare, a leading provider of comprehensive vision care services in Reseda, Los Angeles, now offers advanced Orthokeratology (Ortho-K) treatments as part of its growing focus on myopia management. With locations in Granada Hills, North Hollywood, and Southern California, the clinic serves patients throughout Los Angeles and the San Fernando Valley with expert care and cutting-edge treatment options.
Orthokeratology is a non-surgical procedure for correcting vision by reshaping the…
ISOThrive Announces Promising Phase 2 Interim Data for Novel Heartburn Treatment …
ISOThrive Inc. announced promising Phase 2 interim data for ISOT-101, a novel NERD treatment for PPI partial-responders. Pharma veteran Mike Walther joins as Chief Strategy Officer, accelerating strategic opportunities. This positions ISOThrive for high-value transactions in a multi-billion-dollar market.
ISOThrive Inc., a clinical-stage biopharmaceutical company, announced interim results from a Phase 2 study of its lead candidate, ISOT-101, for treatment of Non-Erosive Reflux Disease (NERD). The data showed positive trends in…
Tau Inhibitors - Pipeline Insight, 2025: Targeting Tau Pathology to Transform Ne …
Tau protein aggregation is increasingly recognized as a central driver of neuronal dysfunction in Alzheimer's disease and related tauopathies. With amyloid-directed therapies facing challenges, tau-targeting strategies are emerging as the next frontier in disease-modifying treatments for neurodegeneration.
DelveInsight's "Tau Inhibitors - Pipeline Insight, 2025" explores over 20+ candidates aimed at reducing tau hyperphosphorylation, aggregation, and propagation. These include tau monoclonal antibodies, antisense oligonucleotides (ASOs), kinase inhibitors, and small-molecule stabilizers. Leading programs…
Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2025: Advancing …
Dementia associated with Alzheimer's disease (AD) remains a high-burden neurodegenerative condition, with limited disease-modifying therapies approved to date. However, 2025 marks a turning point, as the R&D landscape shifts beyond amyloid-targeted drugs toward novel mechanisms, including tau aggregation inhibitors, neuroinflammation modulators, and synaptic enhancers.
DelveInsight's "Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2025" provides a comprehensive overview of more than 100 assets in development. Key players such as BioVie, Karuna…
Pruritus - Pipeline Insight, 2025: Novel Anti-itch Pathways Emerge as Biotech an …
Pruritus (chronic itch), a common symptom across dermatologic, hepatic, and renal conditions, is gaining recognition as a standalone therapeutic target. With existing treatments offering only symptomatic relief, the pruritus treatment pipeline is expanding rapidly to address both the sensory and inflammatory drivers of the condition.
DelveInsight's "Pruritus - Pipeline Insight, 2025" evaluates over 30+ active pipeline agents, including kappa opioid receptor agonists, IL-31 and JAK inhibitors, neurokinin-1 receptor antagonists, and other…
Chondrosarcoma Market Forecast 2034: Clinical Trials, EMA, PDMA, FDA Approvals, …
(Albany, USA) Chondrosarcoma Market Summary
In 2023, the Chondrosarcoma market across the 7MM reached approximately USD 8.5 million in the US, with incident cases totaling around 2,300. This rare bone cancer, predominantly affecting adults over 40, is the second most common primary bone tumor after osteogenic sarcoma and is mainly diagnosed as Grade II. Despite its low prevalence, the market is anticipated to grow at a notable CAGR through 2034, driven…
Artificial Intelligence in Healthcare Market to Reach USD 196.91 Billion by 2030 …
Mordor Intelligence has published a new report on the Artificial Intelligence in Healthcare Market offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction
According to a 2025 report on AI in healthcare market by Mordor Intelligence, the market is estimated at USD 39.92 billion in 2025 and is projected to reach USD 196.91 billion by 2030, growing at a CAGR of 37.60 percent during the forecast period.
The artificial intelligence…
Chronic Kidney Disease Market Forecast 2034: Clinical Trials, EMA, PDMA, FDA App …
(Albany, USA) Chronic Kidney Disease Summary
The Chronic Kidney Disease (CKD) therapeutics market in the US was valued at approximately USD 2,824 million in 2023 and is projected to grow throughout the forecast period. The US also reported the highest CKD prevalence among the 7MM, with around 40 million cases in 2023, anticipated to rise by 2034. In the same year, about 2 million males and 3 million females in the…
Uveitis Market Forecast 2034: Statistics, Revenue, EMA, PDMA, FDA Approvals, Cli …
(New York, USA) Uveitis Market Summary
In 2022, the Uveitis market across the 7MM was valued at approximately USD 1,468.66 million, with the US contributing the largest share (~USD 759.03 million), driven by increasing prevalence linked to uveitis-associated conditions, heightened disease awareness, and enhanced diagnostic capabilities. Advances in disease classification, multimodal imaging, drug delivery systems, "omics"-based laboratory diagnostics, and ocular immunology have deepened insights into uveitis pathogenesis and susceptibility. Corticosteroids remain…
Glioma Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, …
(New York, USA) Glioma Market Summary
In 2023, DelveInsight estimates the U.S. glioma market at approximately USD 650 million, the largest globally. Despite standard treatments-surgical resection, radiation, temozolomide, and maintenance temozolomide-relapse occurs in ~95% of patients, underscoring limited efficacy. Approved therapies include OPTUNE (Novocure), AVASTIN (Genentech), TEMODAR (Merck), and the TAFINLAR + MEKINIST combo (Novartis). The introduction of bevacizumab biosimilars, such as ZIRABEV (Pfizer, approved 2019) and MVASI (Amgen, approved 2017),…
Drug Formulation Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Drug Formulation Market Size By 2025?
The pharmaceutical formulation market has witnessed robust expansion in the previous years. The market, which stood at $1908.89 billion in 2024, is projected to reach $2064.68 billion in 2025, showcasing a compound annual growth rate (CAGR) of 8.2%. The historic growth of this market…
Transformative Trends Impacting the Dermatology Lasers Market Landscape: Laser-C …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Dermatology Lasers Market Size By 2025?
There has been a robust growth in the past few years in the size of the dermatology lasers market. It is projected to rise from $2.14 billion in 2024 to $2.27 billion the following year with a compound annual growth rate (CAGR) of 6.0%.…
Key Factor Supporting Cystic Fibrosis (CF) Therapeutics Market Development in 20 …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Cystic Fibrosis (CF) Therapeutics Market Size By 2025?
The market size of cystic fibrosis (CF) therapeutics has seen quick expansion in the past few years. It's projected to rise from $7.54 billion in 2024 to $8.31 billion in 2025, experiencing a compound annual growth rate (CAGR) of 10.2%. Factors contributing…
Chronic Pulmonary Hypertension Market Expected to rise, 2034 | COMPASS Pathways, …
The Chronic Pulmonary Hypertension market growth is driven by factors like increase in the prevalence of Chronic Pulmonary Hypertension, investments in research and development, entry of emerging therapies during the study period 2020-2034.
The Chronic Pulmonary Hypertension market report also offers comprehensive insights into the Chronic Pulmonary Hypertension market size, share, Chronic Pulmonary Hypertension epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake…
Diabetic Neuropathy Market Expected to rise, 2034 | Novo Nordisk, Ionis Pharmace …
The Diabetic Neuropathy market growth is driven by factors like increase in the prevalence of Diabetic Neuropathy, investments in research and development, entry of emerging therapies during the study period 2020-2034.
The Diabetic Neuropathy market report also offers comprehensive insights into the Diabetic Neuropathy market size, share, Diabetic Neuropathy epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and companies…
Chronic Lower Back Pain Market Expected to rise, 2034 | Eli Lilly and Company, C …
The Chronic Lower Back Pain market growth is driven by factors like increase in the prevalence of Chronic Lower Back Pain, investments in research and development, entry of emerging therapies during the study period 2020-2034.
The Chronic Lower Back Pain market report also offers comprehensive insights into the Chronic Lower Back Pain market size, share, Chronic Lower Back Pain epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration…
Chronic Obstructive Pulmonary Disease Market Expected to rise, 2034 | AstraZenec …
The Chronic Obstructive Pulmonary Disease market growth is driven by factors like increase in the prevalence of Chronic Obstructive Pulmonary Disease, investments in research and development, entry of emerging therapies during the study period 2020-2034.
The Chronic Obstructive Pulmonary Disease market report also offers comprehensive insights into the Chronic Obstructive Pulmonary Disease market size, share, Chronic Obstructive Pulmonary Disease epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration…
Go To Page 10998 10997 10996 10995 10994 10993 10992 10991 10990 10989 8358 8357 8356 8355 8354 8353 8352 8351 8350 8349
